Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 2880379011 | Everolimus 250microgram tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 2881825016 | Everolimus 250microgram tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 3474093016 | Everolimus 0.25 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3474094010 | Product containing everolimus 0.25 milligram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3488169011 | Product containing everolimus 0.25 milligram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3570863012 | Product containing only everolimus 0.25 milligram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3570864018 | Product containing only everolimus 0.25 milligram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3699831019 | Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 3699832014 | Everolimus 250 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3699833016 | Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 80769201000001118 | Everolimus 250microgram tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Is a | Product containing everolimus | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has active ingredient | Everolimus | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has active ingredient | Everolimus | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has basis of strength substance | Everolimus | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.25 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Is a | Product containing everolimus in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has precise active ingredient | Everolimus | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Is a | Product containing only everolimus in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has active ingredient | Everolimus | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Is a | Everolimus | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has specific active ingredient | Everolimus | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Zortress 250microgram tablets (Imported (United States)) | Is a | True | Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Everolimus 250microgram tablets 60 tablet | Has VMP | True | Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Certican 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) | Is a | True | Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets